This study analyzes the US enzyme industry. It presents historical demand data for the years 1999, 2004 and 2009, and forecasts for 2014 and 2019 by market (e.g., pharmaceuticals, starch processing, research and biotechnology, food and beverage processing, cleaning products, diagnostics, animal feed), and product (e.g., carbohydrases, proteases, polymerases, nucleases, lipases). The study also considers market environment factors, details industry structure, evaluates company market share and profiles industry competitors.

Demand for pharmaceutical packaging in the US is forecast to increase 5.3 percent annually through 2014. Gains will be driven by recently upgraded regulations and standards that will boost demand for high value-added containers and accessories. Parenteral containers and labels will be among the fastest growing types.

US retail spending on pet health products and services will rise 6.5 percent annually through 2014. Pet insurance will be the fastest growing service from a small base. Pharmaceuticals recently became the largest product category--surpassing parasiticides--and will be among the fastest growing, second only to dietary supplements.

US demand for vaccines will advance 5.6 percent annually through 2014, driven by the development of new vaccines to treat complex human diseases, such as cancer. Public health recommendations for adult and adolescent immunization will produce continued strong sales in this segment, which has reached the level of pediatric vaccines sales.

US demand for nanosized medical products will grow 17.1 percent annually through 2014. Cancer and central nervous system disorders will be the fastest growing applications. Nanomedicines will provide the best opportunities, while nanotech medical supplies and devices grow the fastest from a small base.

US demand for implantable medical devices will increase 8.3 percent annually through 2014. Gains will be driven by the development of next generation devices based on new technologies and improved materials. Spinal implants, cardiac stents and orthobiologics will be among the fastest growing product categories.

Global nanomaterial demand will rise 21 percent annually through 2013. Health care will surpass electronics as the largest market in value terms by 2013, while the energy market grows the fastest. The US, Western Europe and Japan will remain the largest markets, while demand in China leads gains.

Global wound management product demand will rise 4.6 percent yearly through 2013. Best growth prospects include tissue sealants, foam and alginate wound dressings, growth factors, bioengineered tissue substitutes and anti-adhesion agents. China will be the fastest growing market, while the US remains the largest.

Global nutraceutical ingredient demand will rise 6.2 percent annually through 2013. China and India will be the fastest growing national markets while the US remains the largest. Best prospects include soy proteins; additives lutein and lycopene; vitamins A and E; minerals calcium and magnesium; and extracts ginkgo biloba and glucosamine.

US demand for infection prevention products and services will increase 4.8 percent annually through 2013. The best growth opportunities are anticipated in safety-enhanced devices that reduce the risk of health care acquired infections. Medical waste disposal and sterilization supplies, as well as high level disinfectants, will also do well.